Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00883142 · ClinicalTrials.gov registry record

Functional and Physiological Responses to Lokomat Therapy (Pilot Study)

A clinical trial of Stroke and Multiple Sclerosis, sponsored by US Department of Veterans Affairs.

Completed
Registry status
27
Enrollment target
1
Study location

NCT00883142: Completed study of Stroke and Multiple Sclerosis, sponsored by US Department of Veterans Affairs.

NCT00883142 is a study of Stroke and Multiple Sclerosis that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 27 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00883142, a study of Stroke and Multiple Sclerosis, has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
27 participants
Enrollment target
1
Study location

Study Summary

Individuals with neurological deficiencies such as those who have spinal cord injury, stroke, traumatic brain injury, Parkinson's disease, and multiple sclerosis often lose their ability to ambulate over ground. Loss of functional mobility not only impedes everyday life, but may also affect many systems and organs in the body. The investigators are interested in obtaining a wide variety of data in order to obtain a better understanding of changes that occur as a result of receiving Lokomat therapy. The investigators will be studying body composition, cardiac, pulmonary, endocrine, metabolic, and molecular changes after a 12-week clinical therapy program.

Study Locations (1)

New York

  • VA Medical Center, Bronx - The Bronx

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2006-10
Est. Completion 2013-03
US Department of Veterans Affairs

632 total trials

What the finished NCT00883142 record still lists

NCT00883142 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).

The record links to 3 conditions, with Stroke appearing as the primary indexed condition, and to 0 interventions.

NCT00883142 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT00883142 about?

NCT00883142 is a clinical study titled "Functional and Physiological Responses to Lokomat Therapy (Pilot Study)". Individuals with neurological deficiencies such as those who have spinal cord injury, stroke, traumatic brain injury, Parkinson's disease, and multiple sclerosis often lose their ability to ambulate over ground. Loss of functional mobility not only impedes everyday life, but may also affect many sys...

What is the current status of trial NCT00883142?

This trial is currently completed. The enrollment target is 27 participants. The study started on 2006-10. Estimated completion is 2013-03.

What conditions does trial NCT00883142 study?

This clinical trial studies the following conditions: Stroke, Multiple Sclerosis, Spinal Cord Injuries.

Who is sponsoring clinical trial NCT00883142?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00883142 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00883142's enrollment target sits among peer trials

27 322nd of 454 higher than 131 of 454 other Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00912041 · 27 participants · NA

    BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia

  • NCT02847559 · 27 participants · Phase 2

    Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma

  • NCT03380195 · 27 participants · NA

    Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness

  • NCT03384238 · 27 participants · Phase 1

    Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00883142, the US trial registry maintained by the National Library of Medicine. NCT00883142 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.